Central Trust Company’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-240
Closed 1233
2016
Q3
$0 Hold
240
﹤0.01% 1227
2016
Q2
$0 Hold
240
﹤0.01% 1202
2016
Q1
$0 Hold
240
﹤0.01% 1221
2015
Q4
$0 Hold
240
﹤0.01% 1255
2015
Q3
$0 Hold
240
﹤0.01% 1296
2015
Q2
$0 Hold
240
﹤0.01% 1265
2015
Q1
$0 Hold
240
﹤0.01% 1241
2014
Q4
$1K Hold
240
﹤0.01% 1181
2014
Q3
$2K Sell
240
-20
-8% -$198 ﹤0.01% 1157
2014
Q2
$4K Buy
+260
New +$4.51K ﹤0.01% 1098

Central Trust Company's RCPI Position: Q4 2016 in Review

Central Trust Company sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2016, closing a stake of 240 shares.

Central Trust Company first reported a position in RCPI in Q2 2014 and held it in 10 quarters. The position peaked at $4K in Q2 2014. 1 fund tracked by Wall St. Rank holds RCPI as of Q4 2016.

  • Central Trust Company reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Central Trust Company sold 240 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2016.
  • Central Trust Company first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 10 quarters.
  • Central Trust Company's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $4K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2016.

Based on Central Trust Company's 13F filing for Q4 2016, filed 24 Jan 2017.